Neuropharma
Park City, US · Founded 2020 · Delaware corporation
Founders & leadership
JB
Jed BlackNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 1 round · 2020
▶$2.1MraisedDec 2020 · 7 investors · BiotechnologyRule 506(b)
▶$2.1MraisedDec 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jed BlackExecutive Officer, Director
- Offering amount
- $5.2M
- Amount sold
- $2.1M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Neuropharma raised?
- Neuropharma has disclosed $2.1M raised across 1 round.
- Where is Neuropharma headquartered?
- Neuropharma is headquartered in Park City, US.